Development and bio-predictive evaluation of biopharmaceutical properties of sustained-release tablets with a novel gpr40 agonist for a first-in-human clinical trial

HIGHLIGHTS

  • who: Ewelina Juszczyk and colleagues from the Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Su0301wiu02dbecickiego St, Poznanu0301, Poland have published the research work: Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial, in the Journal: Pharmaceutics 2021, x of /2021/
  • what: The aim of this paper is to propose a general workflow for the successful development of a novel SR tablet with an innovative API. The proposed step-by-step approach focuses on employing various analytical . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?